Ciproxifan maleate (CAS No 184025-19-2) is a potent histamine H3 receptor antagonist primarily studied in the field of neuropharmacology Originating from synthetic chemical research it functions by selectively blocking H3 receptors which modulate the release of histamine and other neurotransmitters in the brain influencing cognition and wakefulness In vitro studies show activity in the nanomolar to low micromolar range demonstrating its high affinity and specificity for the target receptor It is commonly used in cell models to explore neurological pathways and in animal studies to assess cognitive function and potential therapeutic effects for disorders such as narcolepsy and Alzheimer s disease Ciproxifan maleate is also utilized in drug screening contexts to identify compounds affecting histamine pathways Experimental concentrations typically depend on the specific research design allowing flexibility to accommodate diverse study parameters